Literature DB >> 34820873

Alpha adaptins show isoform-specific association with neurofibrillary tangles in Alzheimer's disease.

Sukanya Srinivasan1, Jozsef Gal2,3, Adam Bachstetter1,2,3, Peter T Nelson1,4.   

Abstract

AIMS: The heterotetrameric assembly protein complex 2 (AP-2) is a central hub for clathrin-dependent endocytosis. The AP-2 α-adaptin subunit has two major isoforms, encoded by two separate genes: AP2A1 and AP2A2. Endocytosis has been implicated in the pathogenesis of neurodegenerative disease, and recent studies linked α-adaptins (gene variants, splicing defects and altered expression) with late-onset Alzheimer's disease (LOAD) risk. Here, we used multiple antibodies to investigate α-adaptin isoforms and their localization in human brains.
METHODS: The specificities of 10 different α-adaptin antibodies were evaluated using immunoblots after human AP2A1 and AP2A2 plasmid transfection in cultured cells. Additional immunoblot analyses were then performed on protein homogenates from control and LOAD subjects. Formalin-fixed, paraffin-embedded brain sections from control and LOAD subjects were immunohistochemically stained, and immunofluorescence experiments were performed for quantitation of colocalisation with digital image analysis.
RESULTS: Eight of the 10 evaluated antibodies recognised transfected α-adaptin proteins on immunoblots. The α-adaptin subspecies were relatively uniformly expressed in five different human brain regions. The α-adaptins were present in the detergent-insoluble fraction from cognitively impaired, but less so in control, brains. Immunohistochemical analyses showed colocalisation of AP2A1 with tau pathology in LOAD brains. By contrast, AP2A2 colocalised with microglial cells.
CONCLUSIONS: These observations provide evidence of isoform-specific changes of α-adaptins in the brains of LOAD subjects. Antibodies that were verified to recognise AP2A1, but not AP2A2, labelled neurofibrillary tangles of LOAD patients. The findings extend our understanding of AP-2 proteins in the human brain in healthy and diseased states.
© 2021 British Neuropathological Society.

Entities:  

Keywords:  CCV; endolysosomal; human genetics; microglia; neuropathology; tau; tauopathy

Mesh:

Substances:

Year:  2021        PMID: 34820873      PMCID: PMC8810620          DOI: 10.1111/nan.12776

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  39 in total

1.  Calpain hydrolysis of alpha- and beta2-adaptins decreases clathrin-dependent endocytosis and may promote neurodegeneration.

Authors:  Nikita Rudinskiy; Yulia Grishchuk; Anne Vaslin; Julien Puyal; André Delacourte; Harald Hirling; Peter G H Clarke; Ruth Luthi-Carter
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

2.  Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus.

Authors:  Ben Readhead; Jean-Vianney Haure-Mirande; Cory C Funk; Matthew A Richards; Paul Shannon; Vahram Haroutunian; Mary Sano; Winnie S Liang; Noam D Beckmann; Nathan D Price; Eric M Reiman; Eric E Schadt; Michelle E Ehrlich; Sam Gandy; Joel T Dudley
Journal:  Neuron       Date:  2018-06-21       Impact factor: 17.173

3.  Cloning, physical mapping and structural characterization of the human alpha(A)-adaptin gene.

Authors:  Andreas Scorilas; Michael A Levesque; Linda K Ashworth; Eleftherios P Diamandis
Journal:  Gene       Date:  2002-05-01       Impact factor: 3.688

4.  Overlapping but distinct TDP-43 and tau pathologic patterns in aged hippocampi.

Authors:  Vanessa D Smith; Adam D Bachstetter; Eseosa Ighodaro; Kelly Roberts; Erin L Abner; David W Fardo; Peter T Nelson
Journal:  Brain Pathol       Date:  2017-03-24       Impact factor: 6.508

5.  Loss of Bin1 Promotes the Propagation of Tau Pathology.

Authors:  Sara Calafate; William Flavin; Patrik Verstreken; Diederik Moechars
Journal:  Cell Rep       Date:  2016-10-18       Impact factor: 9.423

6.  Adaptor complex AP2/PICALM, through interaction with LC3, targets Alzheimer's APP-CTF for terminal degradation via autophagy.

Authors:  Yuan Tian; Jerry C Chang; Emily Y Fan; Marc Flajolet; Paul Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-25       Impact factor: 11.205

7.  Physiological blood-brain transport is impaired with age by a shift in transcytosis.

Authors:  Andrew C Yang; Marc Y Stevens; Michelle B Chen; Davis P Lee; Daniel Stähli; David Gate; Kévin Contrepois; Winnie Chen; Tal Iram; Lichao Zhang; Ryan T Vest; Aisling Chaney; Benoit Lehallier; Niclas Olsson; Haley du Bois; Ryan Hsieh; Haley C Cropper; Daniela Berdnik; Lulin Li; Elizabeth Y Wang; Gavin M Traber; Carolyn R Bertozzi; Jian Luo; Michael P Snyder; Joshua E Elias; Stephen R Quake; Michelle L James; Tony Wyss-Coray
Journal:  Nature       Date:  2020-07-01       Impact factor: 69.504

8.  Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease.

Authors:  J C Lambert; C A Ibrahim-Verbaas; D Harold; A C Naj; R Sims; C Bellenguez; A L DeStafano; J C Bis; G W Beecham; B Grenier-Boley; G Russo; T A Thorton-Wells; N Jones; A V Smith; V Chouraki; C Thomas; M A Ikram; D Zelenika; B N Vardarajan; Y Kamatani; C F Lin; A Gerrish; H Schmidt; B Kunkle; M L Dunstan; A Ruiz; M T Bihoreau; S H Choi; C Reitz; F Pasquier; C Cruchaga; D Craig; N Amin; C Berr; O L Lopez; P L De Jager; V Deramecourt; J A Johnston; D Evans; S Lovestone; L Letenneur; F J Morón; D C Rubinsztein; G Eiriksdottir; K Sleegers; A M Goate; N Fiévet; M W Huentelman; M Gill; K Brown; M I Kamboh; L Keller; P Barberger-Gateau; B McGuiness; E B Larson; R Green; A J Myers; C Dufouil; S Todd; D Wallon; S Love; E Rogaeva; J Gallacher; P St George-Hyslop; J Clarimon; A Lleo; A Bayer; D W Tsuang; L Yu; M Tsolaki; P Bossù; G Spalletta; P Proitsi; J Collinge; S Sorbi; F Sanchez-Garcia; N C Fox; J Hardy; M C Deniz Naranjo; P Bosco; R Clarke; C Brayne; D Galimberti; M Mancuso; F Matthews; S Moebus; P Mecocci; M Del Zompo; W Maier; H Hampel; A Pilotto; M Bullido; F Panza; P Caffarra; B Nacmias; J R Gilbert; M Mayhaus; L Lannefelt; H Hakonarson; S Pichler; M M Carrasquillo; M Ingelsson; D Beekly; V Alvarez; F Zou; O Valladares; S G Younkin; E Coto; K L Hamilton-Nelson; W Gu; C Razquin; P Pastor; I Mateo; M J Owen; K M Faber; P V Jonsson; O Combarros; M C O'Donovan; L B Cantwell; H Soininen; D Blacker; S Mead; T H Mosley; D A Bennett; T B Harris; L Fratiglioni; C Holmes; R F de Bruijn; P Passmore; T J Montine; K Bettens; J I Rotter; A Brice; K Morgan; T M Foroud; W A Kukull; D Hannequin; J F Powell; M A Nalls; K Ritchie; K L Lunetta; J S Kauwe; E Boerwinkle; M Riemenschneider; M Boada; M Hiltuenen; E R Martin; R Schmidt; D Rujescu; L S Wang; J F Dartigues; R Mayeux; C Tzourio; A Hofman; M M Nöthen; C Graff; B M Psaty; L Jones; J L Haines; P A Holmans; M Lathrop; M A Pericak-Vance; L J Launer; L A Farrer; C M van Duijn; C Van Broeckhoven; V Moskvina; S Seshadri; J Williams; G D Schellenberg; P Amouyel
Journal:  Nat Genet       Date:  2013-10-27       Impact factor: 38.330

9.  Temporal Ordering in Endocytic Clathrin-Coated Vesicle Formation via AP2 Phosphorylation.

Authors:  Antoni G Wrobel; Zuzana Kadlecova; Jan Kamenicky; Ji-Chun Yang; Torsten Herrmann; Bernard T Kelly; Airlie J McCoy; Philip R Evans; Stephen Martin; Stefan Müller; Susanne Salomon; Filip Sroubek; David Neuhaus; Stefan Höning; David J Owen
Journal:  Dev Cell       Date:  2019-08-19       Impact factor: 12.270

Review 10.  Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy.

Authors:  Shanya Jiang; Kiran Bhaskar
Journal:  Front Mol Neurosci       Date:  2020-10-16       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.